Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 To SMILE or not: supportive care matters.

× No keyword cloud information.

5 in total

1. Trial of LVDP regimen (L-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma.

Authors: Y Q Wang; Y Yang; H Y Zhuo; L Q Zou; Y Jiang; M Jiang
Journal: Med Oncol Date: 2015-01-09 Impact factor: 3.064

2. Combined therapy in untreated patients improves outcome in nasal NK/T lymphoma: results of a clinical trial.

Authors: Agustin Avilés; Natividad Neri; Raúl Fernández; Judith Huerta-Guzmán; Maria-Jesus Nambo
Journal: Med Oncol Date: 2013-06-25 Impact factor: 3.064

Review 3. Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas.

Authors: Jason Yongsheng Chan; Soon Thye Lim
Journal: Int J Hematol Date: 2018-01-29 Impact factor: 2.490

4. [Efficacy of GLIDE chemotherapy for patients with newly diagnosed advanced-stage or relapsed/refractory extranodal natural killer cell lymphoma].

Authors: J Ji; B Xiang; Z G Liu; Y Q Jia; H L Zhu; T Niu; L Pan; H Chang; J Huang; Y Wu; J J Li; C He; H B Ma; Y Tang; T Dong; T Liu
Journal: Zhonghua Xue Ye Xue Za Zhi Date: 2016-09-14

5. The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type.

Authors: Lei Zhang; Sucai Li; Sisi Jia; Feifei Nan; Zhaoming Li; Jingyu Cao; Shanshan Fan; Chao Zhang; Liping Su; Jinghua Wang; Hongwei Xue; Mingzhi Zhang
Journal: Oncotarget Date: 2016-09-06

5 in total